Quarterly report [Sections 13 or 15(d)]

Cash, Cash Equivalents, and Marketable Securities (Tables)

v3.26.3
Cash, Cash Equivalents, and Marketable Securities (Tables)
9 Months Ended
Sep. 30, 2026
Cash, Cash Equivalents, and Marketable Securities [Abstract]  
Schedule of Investments

The following table summarizes the Company’s investments as of September 30, 2026 (in thousands):

 

   

Amortized

Cost Basis

   

Unrealized

Gains

   

Unrealized

Losses

   

Estimated

Fair Value

 
                         
Cash   $ 41,966     $     -     $ -     $ 41,966  
Investments in corporate bonds     17,032       -       (26 )     17,006  
Total cash, cash equivalents and investments in marketable securities   $ 58,998     $ -     $ (26 )   $ 58,972  

 

The following table summarizes the Company’s investments as of December 31, 2025 (in thousands):

 

   

Amortized

Cost Basis

   

Unrealized

Gains

   

Unrealized

Losses

   

Estimated

Fair Value

 
                         
Cash   $ 24,172     $     -     $ -     $ 24,172  
U.S. Treasury Bills     3,449       -       -       3,449  
Money Market     1,577                       1,577  
Investments in corporate bonds     12,072       -       (1 )     12,071  
Total cash, cash equivalents and investments in marketable securities   $ 41,270     $ -     $ (1 )   $ 41,269